Clinical trialNCT00839007CompletedPhase 2Interventional

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

SponsorNile TherapeuticsEnrollment77Acute Decompensated Heart Failure

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of the study is to assess the safety and tolerability of IV administration of CD-NP and the dose relationship of CD-NP on improvement of clinical symptoms and renal function in ADHF patients.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Hsiao Lieu, MD
Nile Therapeutics
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany

Facility name not stated
Berlin, Germany
Facility name not stated
Berlin, Germany
Facility name not stated
Dortmund, Germany
Facility name not stated
Neuss, Germany
Facility name not stated
Würzberg, Germany

Israel

Facility name not stated
Ashkelon, Israel
Facility name not stated
Haifa, Israel
Facility name not stated
Nazareth, Israel
Facility name not stated
Petah Tikva, Israel
Facility name not stated
Safed, Israel
Facility name not stated
Tel Aviv, Israel

United States

Facility name not stated
Los Angeles, California, United States
Facility name not stated
Torrance, California, United States
Facility name not stated
Jacksonville, Florida, United States
Facility name not stated
Miami Beach, Florida, United States
Facility name not stated
Chicago, Illinois, United States
Facility name not stated
Iowa City, Iowa, United States
Facility name not stated
Detroit, Michigan, United States
Facility name not stated
Minneapolis, Minnesota, United States
Facility name not stated
The Bronx, New York, United States
Facility name not stated
Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cenderitide

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2009
Primary completion: 30 Jun 2010
Completion: 31 Jul 2010
Last update posted: 17 Sept 2010
Registered enrollment: 77
Registry id: NCT00839007

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.